Low dose BCG regimen in T1 transitional cell carcinoma of the bladder: long term results.

Journal of the Egyptian National Cancer Institute

Volumn 21, Issue 2, 2009, Pages 151-155

  Kamel, Ahmed I ^a   El Baz, Ahmed G ^b   Abdel Salam, Wael T ^b   El Din Ryad, Mahmoud E ^b   Mahena, Ahmed A ^b  

^a Egypt   (Egypt)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; BLADDER TUMOR; CANCER STAGING; DISEASE COURSE; FOLLOW UP; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADMINISTRATION, INTRAVESICAL; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 79952277065     PISSN: 11100362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)